Evidence map›Paper›PMID 33880578›Full record

ReviewMolecular medicine reports2021

Major signaling pathways and key mediators of macrophages in acute kidney injury (Review).

Ning Li, Jiale Chen, Pengtao Wang, Haojun Fan, Shike Hou, Yanhua Gong

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Molecular medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06473844 (Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Sepsis), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06473844 narecruitingnot on this mapstarted 2025, after this paper: background citation

Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Sepsis: A Feasibility Study for a Multicenter Double-Blind Randomized Placebo-Controlled Trial

TypeinterventionalSponsorHospital Authority, Hong KongRan2025 to 2027Enrolled60ConditionsSepsis, Inflammation, SGLT2 Inhibitors, Critically IllArmsEmpagliflozin 10 MG, Placebo
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Macrophage angiotensin ATAmerican journal of physiology. Renal physiology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ning Li *Institute of Disaster Medicine, Tianjin University, Tianjin 300072, P.R. China.
Jiale Chen *Institute of Disaster Medicine, Tianjin University, Tianjin 300072, P.R. China.
Pengtao WangTianjin Key Laboratory of Disaster Medicine Technology, Tianjin 300072, P.R. China.
Haojun FanInstitute of Disaster Medicine, Tianjin University, Tianjin 300072, P.R. China.
Shike HouInstitute of Disaster Medicine, Tianjin University, Tianjin 300072, P.R. China.
Yanhua GongInstitute of Disaster Medicine, Tianjin University, Tianjin 300072, P.R. China.
Tianjin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) has become a global public health problem with high morbidity and mortality rates, as well as high healthcare costs. Immune cells, particularly macrophages, which regulate tissue development, destroy pathogens, control homeostasis and repair wounds, play crucial and complex roles in AKI. In various types of AKI, numerous rapidly recruited monocytes and tissue‑resident macrophages act in a coordinated manner. Thus, elucidating the phenotypic and functional characteristics of macrophages in AKI is essential for identifying potential therapeutic targets. Macrophage‑sensing mediators and macrophage‑derived mediators participate in the major macrophage‑related signaling pathways in AKI, which regulate macrophage polarization and determine disease progression. In conclusion, macrophages change their roles and regulatory mechanisms during the occurrence and development of AKI. The aim of the present review was to contribute to an improved understanding of AKI and to the identification of novel therapeutic targets for this condition.

Indexed as

Signal TransductionAcute Kidney InjuryAnimalsCytokinesHomeostasisHumansKidneyMacrophage ActivationMacrophagesMonocytesCytokinesacute kidney injurymacrophage‑derived mediatorsmacrophage‑sensing mediatorssignal pathway

Identifiers

PMID33880578
PMCPMC8072315
OpenAlexW3156606258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.